Manufacturer record
Poddar Pharmaceuticals Pvt Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Poddar Pharmaceuticals Pvt Ltd (Uttarakhand) were declared Not of Standard Quality between March 2019 and November 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: TO-22, Thyroxine Tablets IP 0.1mg (exp Mar 2026). DTL Chennai (state lab) found it not of standard quality: Sample does not conform to IP Specification for Thyroxine Sodium Tablets With respect to Dissolution and to the Content of Anhydrous. Listed in the November 2024 alert.
Records by type
3 records linked to Poddar Pharmaceuticals Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Thyroxine Tablets IP 0.1mg | Batch TO-22Mfg Apr 2024 · Exp Mar 2026 | Sample does not conform to IP Specification for Thyroxine Sodium Tablets With respect to Dissolution and to the Content of Anhydrous Thyroxine sodium in Thyroxine Sodium.Dissolution | DTL ChennaiState lab | Nov 2024 |
| Thyroxine Tablets IP 0.1mg | Batch TN-27Mfg Dec 2023 · Exp Nov 2025 | Sample does not conform to IP Specification for Thyroxine Sodium Tablets With respect to Dissolution and to the Content of Anhydrous Thyroxine sodium in Thyroxine Sodium.Dissolution | DTL ChennaiState lab | Nov 2024 |
| MISOPROSTOL TABLETS IP 200 MCG | Batch TD-13Mfg Jul 2018 · Exp Dec 2019 | Assay of MisoprostolAssay | RDTL ChandigarhCDSCO lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.